IP Library Granted Patent US 9,359,590
Granted Patent B2
US 9,359,590 · App. 11/667,865 · Granted Jun 7, 2016

Derivation and culture of human embryo-derived cells

Inventors: Teija Tuulikki Peura (Yeronga, AU); Robert Paul Siebrand Jansen (Killara, AU)
Assignee: SYDNEY IVF LIMITED
C12N5/0604C12N5/0606A61K35/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,359,590
App. No.
11/667,865
Granted
Jun 7, 2016
Kind
B2
Abstract

The present invention concerns methods for deriving and culturing embryonic cells and in particular to methods for maintaining the undifferentiated state of stems cells and cell lines in culture. The invention also concerns cells and cell lines derived by the methods of the invention.

Claims (16)

1. A method of derivation of embryo-derived cells or embryo-derived cell lines consisting of the following steps:

a) culturing an embryo under low oxygen tension conditions of about 5% oxygen to the blastocyst stage;

b) separating Inner Cell Mass (ICM) cells of said blastocyst from trophectodermal cells, plating said ICM cells and culturing said ICM cells under low oxygen tension conditions of about 5% oxygen for a time sufficient to produce embryonic cell-like outgrowths;

c) at least once, dissociating said embryonic cell-like outgrowths, replating said dissociated embryonic cell-like outgrowths and culturing said dissociated embryonic cell-like outgrowths under low oxygen tension conditions of about 5% oxygen for a time sufficient to produce further embryonic cell-like outgrowths;

d) analyzing said further embryonic cell-like outgrowths of step c) for embryonic stem cell-like properties;

e) selecting outgrowths with embryonic stem cell-like properties; and

f) isolating and dissociating said outgrowths with embryonic stem cell-like properties selected in step e) and culturing the dissociated cells under low oxygen tension conditions of about 5% oxygen to obtain embryo-derived cells or embryo-derived cell lines.

2. A method of derivation of embryo-derived cells or embryo-derived cell lines consisting of the following steps:

a) incubating a putative zygote in a culture medium under low oxygen tension conditions of about 5% oxygen to derive an embryo;

b) culturing embryo obtained in step a) under low oxygen tension conditions of about 5% oxygen to the blastocyst stage;

c) separating Inner Cell Mass (ICM) cells of said blastocyst from trophectodermal cells, plating said ICM cells and culturing said ICM cells under low oxygen tension conditions of about 5% oxygen for a time sufficient to produce embryonic cell-like outgrowths;

d) at least once, dissociating said embryonic cell-like outgrowths, replating said dissociated embryonic cell-like outgrowths and culturing said dissociated embryonic cell-like outgrowths under low oxygen tension conditions of about 5% oxygen for a time sufficient to produce further embryonic cell-like outgrowths;

e) analyzing said further embryonic cell-like outgrowths of step d) for embryonic stem cell-like properties;

f) selecting outgrowths with embryonic stem cell-like properties;

g) isolating and dissociating said outgrowths with embryonic stem cell-like properties selected in step f) and culturing the dissociated cells under low oxygen tension conditions of about 5% oxygen to obtain embryo-derived cells or embryo-derived cell lines.

3. The method according to claim 1 or 2 , wherein the embryo-derived cell or embryo-derived cell line is a stem cell or stem cell line.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2019
From: GENEA IP HOLDINGS PTY LIMITED
To: GENEA BIOCELLS USA (HOLDINGS), INC.
Reel/Frame 050088/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2019
From: GENEA BIOCELLS USA (HOLDINGS), INC.
To: SONIC MASTER LIMITED
Reel/Frame 050088/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2018
From: GENEA IP HOLDINGS PTY LIMITED
To: GENEA BIOCELLS USA (HOLDINGS), INC.
Reel/Frame 046626/0719 →
CHANGE OF NAME Recorded Aug 9, 2018
From: SYDNEY IVF LIMITED
To: GENEA LIMITED
Reel/Frame 046758/0453 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2017
From: GENEA LIMITED
To: GENEA IP HOLDINGS PTY LTD
Reel/Frame 044899/0344 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 019945 FRAME: 0615. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 15, 2016
From: PEURA, TEIJA TUULIKKI; JANSEN, ROBERT PAUL SIEBRAND
To: SYDNEY IVF LIMITED
Reel/Frame 038087/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2007
From: PEURA, TEIJA TUULIKKI; JANSEN, ROBERT PAUL SIEBRAND
To: SYDNEY IVF LIMITED
Reel/Frame 019945/0615 →
Priority Claims (1)
AU 2004906554 · Nov 16, 2004 · national
Continuity (1)
Related Publication 20080050813A1 · Feb 28, 2008